SoftBank-backed Neumora valued at $2.51 billion in lukewarm debut
By Jaiveer Shekhawat (Reuters) -Shares of Neumora Therapeutics, which is backed by Amgen and Japan’s SoftBank, fell in their market debut on Friday, giving the company a market capitalization of $2.51 billion.…
